+34 620 10 75 37info@nanbiosis.com

News

nanbiosis news

NANBIOSIS Unit 18 expands its equipments and capabilities

NANBIOSIS U18 Nanotoxicology Unit, led by Dr. Dr. Ramón Mangues, has recently added new equipment as a result of its participation in the project FICTS1420-20, selected by the MINECO for co-financing by the FEDER Program in ICTS 2014-2020.

The new equipment consists in a Autostainer System for the automation of manual staining methods used in Immunohistochemistry, pharmacodiagnostic, immunofluorescence and chromogenic development for in situ hybridization (AUTOSTAINER-TOX). Includes small equipment for deparaffinization, hydration and antigenic unmasking of paraffin-embedded tissue, complete kit for deparaffinization, hydration and antigenic unmasking of paraffin-embedded tissue. The equipment management software allows monitoring of staining status, request requests, and reporting and obtaining statistics.

European Regional Development Fund
Read More

“Tips and tricks to achieve good results at the bench”

The IBEC Core Facilities team, coordinating NANBIOSIS U7 Nanotechnology Unit has celebrated the 6th edition of the Workshop “Tips and tricks to achieve good results at the bench”.

This workshop is focused on fundamental basic aspects of working in a Chemistry/Biology laboratory: process of performing an experiment, from previous planning until the moment of leaving the bench.

The workshop was divided in two parts:

  • Introduction and overview to the Good Laboratory  Practices.
  • Highly interactive and practical daily lab situations with real equipment.

Upon completion of this workshop participants are able to understand the basics of good laboratory practices, plan an experiment taking into account all the steps necessary to perform it, use several basic equipment (scale, centrifuge, pHmeter, biosafety cabinet/sterile technique, handing liquids) and classify several types of hazardous waste.

Read More

Carlos Rodriguez-Abreu (NANBIOSIS U12) keynote speaker in OKINAWA COLLOIDS 2019


Carlos Rodriguez-Abreu, Scientific Director of NANBIOSIS U12 Nanostructured liquid characterization unit has been invited speaker at OKINAWA COLLOIDS 2019 conference in Okinawa, Japan on November 3 to 8, 2019 in the session Foams / Bubbles / Emulsions and Microemulsions.
Foams and emulsions stabilized by surfactants, amphiphilic polymers and solid particles are essential formulations for developing pharmaceuticals, cosmetics, foods and so on. Recently, many functional systems have been proposed including stimuli responsive materials, biocompatible materials, and environmental affinity materials. The topics of this session include a wide range of subjects: physical properties, phase behaviors and new functions of these systems.

Read More

NANBIOSIS internal dissemination day

NANBIOSIS has celebrated today the second edition of NANBIOSIS internal dissemination day, at the ICMAB-CSIC, Barcelona.

The Day has been focuss on the staff that deals with the day-to-day work of the units, especially technical staff. The event was attended by technicians and coordinators of the units of Catalonia and Aragon (almost 30 face-to-face assistants) and has been followed through the streaming broadcast by the other units.

The day has been presented by the NANBIOSIS Scientific Director Jaume Veciana and the Nerea Argárate Coordinator, followed by a round of presentations by the attendees and their work in the different NANBIOSIS units.

The first part has focused on the Cutting Edge Biomedical Solutions as integral solutions to the problems that arise in biomedical research integrating the expertise of several units presented by Nerea Argarate, as well as several presentations from the units of the Minima invasion Surgery Center Jesus Usón de Cáceres CCMIJU by Javier García, Jorge Bote and Verónica Crisóstomo focused on potential internal collaborations, synergies and complementarities in NANBIOSIS between the CIBER, CCMIJU and Bionand units.

Javier García Casado CCMIJU

The second part dealt with the implementation of quality systems, the NANBIOSIS coordinator has presented the NANBIOSIS Quality Plan and Arnau Jaumandreu (NANBIOSIS Unit 6 Technician) has made a good summary of the steps to follow in the implementation of a quality system with recommendations from its experience in the process followed by unit 6, all followed by a debate.

Arnau Jaumandreu

In the last part Anna May Masnou (Head of Communication and Dissemination of ICMAB-CSIC) has spoken about the use of the NANBIOSIS brand and communication channels, the dissemination of science and its returns. The day has ended with a space for debate.

Anna May Masnou ICMAB-CSIC
Read More

NANBIOSIS in the NEW BOOK of the UNIQUE SCIENTIFIC AND TECHNICAL INFRASTRUCTURES (ICTS)

We are pleased to inform that the new book of Unique Scientific and Technical Infrastructures (ICTS) has been published by the Spanish Ministery of Innovation, Science and Universities with the collaborations of the ICTS.

The Spanish Map of Unique Scientific and Technical Infrastructures (ICTS), goups biomedical technologies, cleanrooms, supercomputers, advanced lasers, telescopes, underground laboratories, synchrotrons, particle accelerators, biological reserves, solar, oceanic and hydraulic platforms, oceanographic research ships, and polar bases in Antarctica. A total of 29 ICTS, made up of 62 nodes, allow for ambitious research projects that attract first-rate talent and enhance the technological and innovative industry capacities.

“Through a one-stop system, NANBIOSIS provides comprehensive solutions that are tailored to the challenges thaat researchers face in biomedicine… its configuration means pioneering multidisciplinary studies can be conducted. Some examples are outlined below.”

NANBIOSIS ICTS

Among these examples, several results combining the expertise of several Units of NANBIOSIS: an original method to prepare smaller nanoparticles of polylactic-co-glycolic acid (PLGA) functionalised with cell-penetrating peptides (CPP), which penetrate the cell membrane and release controlled drug doses into the cells; an innovative medication administration system based on emerging bionanotechnology with protein nanoparticles that selectively deliver lead the therapeutic agent to the tumour cells or a bioactive surgical mesh, covered with adult stem cells, to reduce the inflammatory process associated with implanting this type of material that proved a beneficial effect on the biocompatibility in animal models.

As Pedro Duque, Spanish Minister of Innovation, Science and Universities says in its prelude “The Unique Scientific and Technical Infrastructures described in this book are crucial for Spain and its science, technology, and innovation. I encourage you to browse the pages of this book and discover the state-of-the-art infrastructures that represent the scientific and technological capacity that exists in Spain today. You won’t regret it

Read More

Agreement signed with MINECO for the allocation of FEDER funds for NANBIOSIS ICTS

In the framework of the FEDER Program in ICTS 2014-2020, a project related to the ICTS NANBIOSIS has been selected by the Ministry of Science, Innovation and Universities for co-financing with FEDER funds of the European Regional Development Funds program.

An agreement has been signed between the Ministry of Science, Innovation and Universities and the Institute of Bioingeniería of Catalonia (IBEC) for the implementation of the project “Mask Aligner Team for the unit of Nanotechnology (U7) of Nanbiosis” cofinanced by FEDER Performance Program 2014-2020.  The total budget of the project amounts to € 117.000, with 50% financing with FEDER Funds.

IBEC isprocessing the necessary contracting procedures for the execution of this project.

Read More

I ONLINE Course on Introduction to Quality Management in Laboratories in the Biosanitary Field

The Jesús Usón Minimally Invasive Surgery Center (JUMISC), organizes the 1st ONLINE Course on Introduction to Quality Management in Laboratories in the Biosanitary Field.

The course will count with the expertise Beatriz Moreno Lobato, Scientific Director of NANBIOSIS Unit 19 CLINICAL TEST LAB, among others.

The Course is directed to middle-level technicians: Auxiliary Care of Nursing and Pharmacy and Parapharmacy and also to higher degree technicians: Pathological and Cytodiagnostic Anatomy, Oral Hygiene, Image for Diagnosis and Nuclear Medicine, Clinical and Biomedical Laboratory, Dental Prosthetics, Dietary

The course has a capacity for forty attendees and registration is now open here:

The course program consists of:
Thematic Unit 1: Quality Management Systems (7.5h) (15h student dedication)

  • Historical justification and principles of quality management (1,5h) (J Sánchez)
  • Quality Assurance Systems (J Sánchez)
  • ISO 9001 (1,5h) (J Sánchez)
  • ISO 17025 Standard (1,5h) (J Sánchez)
  • BPL regulations (1,5h) (J Fco Guillén)
  • Quality Philosophy. New strategies (1,5h) (J Sánchez)

Thematic Unit 2: Quality in the field of the laboratory (8.5h) (17h student dedication)

  • Generalities and Management in a Clinical Analysis Laboratory (2h) (B Moreno)
  • Safety standards in laboratories (2h) (J Boat)
  • Quality in other laboratories in the biomedical field (4,5h) (N Hernández / J García / N Picado)

Thematic Unit 3: Analytical Quality (4h) (8h student dedication)

  • Definition of analytical quality. General aspects (B Moreno)
  • Analytical tests (B Moreno)
  • Management and conservation of samples. Analytical Interferences (B Moreno)
  • Validation of analytical methods (B Moreno)
  • Calibration and equipment management. Quality and PNT manuals (J Fco Guillén / B Moreno)

Thematic Unit 4: Introduction to GLP (4h) (8h student dedication)

  • Regulation and relationship with other standards (J Fco Guillén)
  • ISO 13485 and other related standards (J Fco Guillén)
  • Documentation and Quality Assurance (J Fco Guillén)
  • BPL applications (B Moreno)

Final exam and Satisfaction Survey (2h)

Read More

Understanding between doctors and engineers: essential to advance in health

Pablo Laguna Lasaosa, New Director of I3A and scientific director of NANBIOSIS U27 High Performance Computing talks about Biomedical Engineering in the radio programm “La Brujula de Aragón” @OndaCero_

Professor of signal and communications, expert of biomedical signals in the cardio vascular domain, Pablo Laguna talks about engineering today and how the relative weight of engineering is nowadays repesented by the information engineering, computer engineering and the treatment of information to be applyed in different domains, new materials and new ways of addressing and solving problems.

For the recently appointed director of the I3A, there is an opportunity in this updated concept of enineering to try to attract the female sector. “In the I3A -says Pablo Laguna- there are a good number of female engineers, pioneer women, of recognized national and international prestige, who make the effort of diffusion so that other women are encouraged to continue their way”.

Doctor Laguna also explains the I3A research which groups forty or fifty research groups in four work domains:

Chemical engineering, what is known as processes and recycling, (recycling, sludge management or new chemical processes to obtain new materials …), with a very close relationship with the recycling industry.

More classic industrial technologies, the mechanical part, where the great chanllenges are in knowledge, in simulations… to give value to companies.

Information and telecommunications technologies, which brings together the technologies of communication, computer science, data management and artificial intelligence.

Engineering applied to the resolution of biological problems, diagnosis of diseases, therapy … interdisciplinarity and understanding between the doctor and the engineer are nowadays essential to advance in the field of health.

To follow the interview in spanish: from min 13:15
https://www.ondacero.es/emisoras/aragon/audios-podcast/brujula/la-brujula-de-aragon-12112019_201911125dcb01af0cf235944927d27e.html

Read More

Pablo Laguna, new director of the Aragon Engineering Research Institute

Pablo Laguna Lasaosa, Scientific Director of Unit 27 High Performance Computing has been elected new director of the Aragon Engineering Research Institute (I3A).

Pablo Laguna Lasaosa, Professor of Signal Theory and Communications at the School of Engineering and Architecture (EINA) of the University of Zaragoza, develops its research activity in the field of signal processing, particularly applied to biomedical applications. Laguna is co-author of more than 150 research articles on this subject, more than 10 book chapters, more than 300 international conference documents and director of 15 doctoral theses. He has led a good number of projects on the interpretation of biomedical signals, especially in the cardiovascular domain, most of them with international collaborations with clinical centers, academia and engineering companies.
 
Proff Laguna holds some international scientific responsibilities as a member (2008-2019) and president (2015-2018) of the board of directors of the Computing in Cardiology conference, as editor of the Digital Signal Processing (Eurasip) and Medical and Biological Engineering (Springer), In addition to organizing different scientific conferences. Select member (fellow) of the Institute of Electrical and Electronics Engineers (IEEE), of the European Alliance for Medical and Biological Engineering & Science (EAMBES) and of the International Academy of Medical and Biological Engineering (IAMBE). He is co-author, together with Dr. L. Sörnmo, of the book Bioelectrical Signal Processing in Cardiac and Neurological Applications (Elsevier, 2005), considered a reference in his field.
 
Within the field of university management and research, Professor Laguna has been a member of I3A since its inception, deputy director of International Relations of EINA (1999-2002), principal investigator of the Biomedical Signal Interpretation and Computational Simulation (BSICoS) group of the I3A, coordinator of the Biomedical Engineering division of the I3A (2000-2011) and its deputy director, responsible for the Master in Biomedical Engineering (2003-2010) and of the Doctoral Program in Biomedical Engineering of the I3A since its creation in 2002 until the present. He has also been the scientific director of the Network Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine CIBER-BBN (2011-2015), where he is still a member.
 
His work program as director of the I3A over the next four years will focus on this important institute of the University of Zaragoza advancing as a reference structure for quality research, multidisciplinary and with a vocation to transfer its results to society.

Read More

III Conference on the Disclosure of Biomedical and Experimental Sciences

The III Conference for the Disclosure of Biomedical and Experimental Sciences will take place at the Center for Minimally Invasive Surgery Jesús Usón of Cáceres, on December 5, 2019. It will be attended by Francisco Miguel Sanchez Margallo, Deputy Scientific Director of NANBIOSIS and Beatriz Moreno Lobato, Scientific Director of Unit 19 of NANBIOSIS

FREE ACTIVITY – Requires prior registration until full capacity is reached

Pre- registration: https://www.ccmijesususon.com/formacion/preinscripcion/1173/

Program:

Read More